IGF-1 LR3 Australia: Buy IGF 1 LR3 Peptide Online

Shop IGF-1 LR3 1 mg With Lot Data and Chemical Identity

Order this analogue when a culture or receptor study needs IGF-1 signalling that holds for days instead of fading as binding proteins take it up. The 1 mg vial is held in Australia and every lot has its own report.

What Is IGF-1 LR3?

IGF-1 LR3 is an engineered, longer version of insulin-like growth factor 1, the hormone that carries out much of growth hormone's work in tissue, altered so that the body's natural binding proteins can barely hold onto it. A larger share stays unbound, which is why it acts more strongly in cell culture than the natural hormone at the same concentration.

What IGF-1 does normally

Native IGF-1 is a small protein of 70 amino acids, folded by three disulfide bridges into a shape closely related to proinsulin. The liver makes most of the circulating supply when growth hormone tells it to, though many tissues produce their own. It acts on the IGF-1 receptor, a tyrosine kinase that sits across the cell membrane as a paired unit. When IGF-1 binds, the receptor phosphorylates itself and recruits adaptor proteins, setting off two main cascades: PI3K and Akt, which favour cell survival and protein synthesis through mTOR, and Ras and MAPK, which push cells to divide.

In blood and in culture, though, very little IGF-1 floats free. Six binding proteins, IGFBP-1 to IGFBP-6, capture it, extend its life in circulation and decide when it can reach a receptor. Many cultured cell lines secrete these binding proteins into their own medium, quietly mopping up any IGF-1 that is added.

How the long analogue gets around that

Two edits do the work. Swapping glutamic acid for arginine at position 3 disturbs one of the surfaces the binding proteins grip, and the 13-residue leader at the front adds further interference. The receptor still recognises the core, so signalling proceeds without the usual interception. When Francis and colleagues compared fusion analogues of this kind in 1992, their conclusion was that weaker capture by binding proteins, rather than tighter receptor binding, accounted for the extra potency in cell assays.

That leads to the point most people get backwards. The IGF-1 LR3 peptide is not a stronger receptor agonist than IGF-1. It is a harder one to intercept. In a serum-free system with cells that make few binding proteins, the gap between long R3 IGF-1 and the native hormone narrows considerably; in serum-supplemented medium, or with cell lines that secrete plenty of IGFBPs, it widens. Our advice is to run native IGF-1 alongside the analogue for any experiment where binding protein levels might change between conditions, otherwise a shift in IGFBP secretion can masquerade as a change in receptor response. Terms such as IGFBP and IGF-1R are defined in our peptide glossary for lab work.

Buy the IGF 1 LR3 Peptide Online, the Culture Analogue Born in Adelaide

The analogue came out of Adelaide in the early 1990s, from the research group that had earlier described des(1-3) IGF-1. The aim was a growth factor that was easier to produce and more stable in use, and the result became a standard supplement for serum-free media, notably for Chinese hamster ovary cells in bioproduction.

Its appeal is durability. Because it binds the six IGF binding proteins only weakly, more of it stays free to reach the receptor, and it degrades slowly in medium, so a single addition can carry a multi-day culture. Buy it as a laboratory reagent, not a therapeutic, from our GH axis and IGF peptides range.

Is IGF-1 LR3 Legal in Australia? An Adelaide Protein Under Schedule 4

Expect a small vial containing 1 mg of Long R3 IGF-1 as a freeze-dried film or pellet, white and easy to overlook, with no carrier protein or buffer added by us. This is the one compound in our growth hormone range with a genuinely Australian commercial story. Beyond the Adelaide laboratory work described above, the protein was manufactured by GroPep Limited in Adelaide as a cell culture raw material, and from 2000 a distribution agreement put it into industrial bioprocessing supply worldwide.

Its cell culture pedigree does not change how the Poisons Standard treats it. Checked against the June 2026 Poisons Standard in October 2026, insulin-like growth factor I appears in Schedule 4 alongside a broader entry, insulin-like growth factors except when separately specified, which captures analogues such as LR3; both entries are marked for Appendix D, clause 5, so possessing it without authority is illegal. The registered relative is mecasermin, recombinant native IGF-1, which has a TGA product information document under the Increlex brand. Long R3 IGF-1 itself has never been approved as a medicine anywhere, so it has no ARTG registration as a medicine and no pharmacy route.

WADA's 2026 Prohibited List names insulin-like growth factor 1 and its analogues among the growth factors in class S2, prohibited at all times, and Sport Integrity Australia applies the same list.

When labs ask where to buy IGF 1 LR3 in Australia with the identity documented, the answer here is a 1 mg vial kept on Australian shelves for in vitro and culture work, which we sell only to adults of 18 or more and which must never be given to a person or an animal. Our peptide storage guide covers freezer and fridge handling for the sealed and mixed vial.

Order IGF-1 LR3 for Sale in One 1 mg Vial With Lot Tracking

We supply one fill, a 1 mg vial at $99. That looks expensive per milligram beside 10 mg secretagogue vials, but working amounts here are measured in nanograms per mL of medium, so one milligram (1,000 micrograms) supplements a large volume. Cost per experiment is the fairer comparison. The fill is small because this is a folded 83 residue protein with three disulfide bonds, far harder to make than a short peptide.

A 1 mg pellet is tiny and can look like an empty vial, and the certificate confirms what is inside. Order two or three vials at once if you run several culture lines, and they will come from the same lot wherever stock allows so the project keeps one certificate. Only adults aged 18 and over can complete checkout.

Shop Long R3 IGF-1 From Stock With Structure, Purity and Certificate

The construct has three parts, the 13 residue extension Met-Phe-Pro-Ala-Met-Pro-Leu-Ser-Ser-Leu-Phe-Val-Asn, then the 70 residues of human IGF-1 with arginine at position 3. A mass close to 9.1 kDa, against about 7.6 kDa for native IGF-1, is the first sign that the vial holds the long analogue rather than the natural hormone.

The certificate should match the formula and CAS in the table and report an HPLC result for your lot. Find it in the COA library, where the COA reading guide shows why the measured mass matters as much as the purity figure.

Order IGF 1 LR3 Australia Wide From One Stock and Store the Vial

No shop or collection point is needed. The online store supplies labs in every state from one Australian stock, and orders paid before 3pm on a business day are dispatched the same afternoon. Groups after research peptides in Adelaide, where the analogue was first made, order the same way. Progress shows on the order tracking page.

Data sheets for IGF analogues often dissolve the stock in a dilute acid, and 0.6% acetic acid is the usual choice here, while bacteriostatic water suits solutions drawn from several times. Add the diluent slowly and swirl rather than shake. With 1 mL, the vial gives 1 mg/mL, which is 1,000 micrograms per mL, and the peptide calculator handles further dilution into working stock.

Keep the sealed LR3 vial at -20 °C, dry and dark. A carrier protein such as 0.1% bovine serum albumin in the diluted stock limits losses to plastic surfaces. In solution, hold it at 2 to 8 °C for short periods, or freeze single-use aliquots for longer runs. Avoid repeated freeze-thaw cycles, which encourage aggregation of the folded protein.

Other Names for Long R3 IGF-1

This analogue is listed as LR3 IGF-1, Long R3 IGF-I, Long Arg3 IGF-1 or simply LR3. The roman numeral form, IGF-I, is common in older journals. All refer to the same 83 residue chain registered under CAS 946870-92-4.

Receptor vocabulary centres on IGF-1R, the insulin-like growth factor 1 receptor, a tyrosine kinase, and on the IGFBPs, the six binding proteins that normally hold native IGF-1 in reserve. Low IGFBP affinity is the defining property of the long analogue.

Long R3 IGF-1 or the CJC-1295 and Ipamorelin Blend, Which to Order

These sit at opposite ends of the growth hormone axis. The CJC-1295 and ipamorelin blend, $65 for 10 mg, acts upstream at the pituitary to trigger growth hormone release, while LR3 skips those steps and acts directly on the receptor that IGF-1 normally reaches last. Pick by the point in the axis your study examines.

Shop LR3 for multi-day cell culture and receptor signalling work. For pituitary secretion studies, a secretagogue is the better purchase, and both can sit in one cart when a project spans the whole axis.